Effect of Rasnadi kwath and Shampakadi Kwath in Vatrakta (hyperuricemia).

An open randomized comparative clinical study of Rasnadi Kwath and Shampakadi kwath in the management of Vatrakta with special reference to hyperuricemia. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075757

Enrollment

Registered

2024-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) All genders will be included 2) Age group -20 to 70 year. 3) All the patients clinically diagnosed as Vatarakta. 4) Patient having uric acid level :- Male 7.0 mg/dl to 12.0 mg/ dl, Female 6.0 to 12 mg/ dl.

Exclusion criteria

Exclusion criteria: 1. Patient with Renal failure. 2. Pregnant and Lactating mothers. 3. Patient with known case of HIV and HbsAg

Design outcomes

Primary

Measure	Time frame
Serum uric acid levelsTimepoint: 21 days	—

Secondary

Measure	Time frame
1. joint pain hypersensitivity at joints Joint stiffness restricted joint movements redness at joints locally swelling around joints burning sensation at jointsTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Vidya Rao

APMs Ayurved Mahavidyalaya Sion Mumbai

drvidyap@yahoo.com9820725950

Outcome results